We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+6.25%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.59B
AUM Growth
+$192M
(+8%)
Cap. Flow
+$86M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
20.43%
Holding
1,510
New
76
Increased
812
Reduced
562
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$9.73M |
| 2 |
JPMorgan Chase
JPM
|
+$9.22M |
| 3 |
DuPont de Nemours
DD
|
+$7.56M |
| 4 |
Bank of America
BAC
|
+$7.18M |
| 5 |
Wells Fargo
WFC
|
+$6.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$6.94M |
| 2 |
Amgen
AMGN
|
+$6.3M |
| 3 |
Johnson & Johnson
JNJ
|
+$4.79M |
| 4 |
Gilead Sciences
GILD
|
+$4.66M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 19.18% |
| 3 | Financials | 11.37% |
| 4 | Communication Services | 10.09% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
COPT Defense Properties
CDP
$4.31B
| $396K | 0.02% |
13,567
-1,557
| -10% | -$48.8K |
|
952
Ollie's Bargain Outlet
OLLI
$4.01B
| $396K | 0.02% |
7,429
+1,107
| +18% | +$52.2K |
|
953
YPF
YPF
$20.2B
| $396K | 0.02% |
17,280
-12,076
| -41% | -$277K |
|
954
Matador Resources
MTDR
$6.31B
| $395K | 0.02% |
12,694
+1,132
| +10% | +$31.1K |
|
955
Grupo Cibest SA
CIB
$20.4B
| $394K | 0.02% |
9,936
-13,363
| -57% | -$541K |
|
956
Prestige Consumer Healthcare
PBH
$2.35B
| $394K | 0.02% |
8,868
-570
| -6% | -$26K |
|
|
MDRX
957
DELISTED
Veradigm Inc. Common Stock
MDRX
| $394K | 0.02% |
27,101
-122,241
| -82% | -$1.7M |
|
958
PENN Entertainment
PENN
$2.74B
| $393K | 0.02% |
12,532
-1,948
| -13% | -$52.6K |
|
959
Advanced Energy
AEIS
$12.2B
| $392K | 0.02% |
5,815
+483
| +9% | +$38.9K |
|
|
ANSS
960
DELISTED
Ansys
ANSS
| $392K | 0.02% |
2,659
-190
| -7% | -$26.9K |
|
961
Cooper Companies
COO
$13.7B
| $392K | 0.02% |
7,200
-2,144
| -23% | -$125K |
|
962
Vistra
VST
$55.1B
| $392K | 0.02% |
21,398
-2,913
| -12% | -$54.6K |
|
|
BZUN
963
Baozun
BZUN
$144M
| $391K | 0.02% |
12,397
+4,730
| +62% | +$153K |
|
964
ICU Medical
ICUI
$3.93B
| $390K | 0.02% |
1,804
+276
| +18% | +$55.9K |
|
|
BCPC
965
Balchem Corp
BCPC
$5.23B
| $389K | 0.02% |
4,829
+869
| +22% | +$72.4K |
|
|
AAN.A
966
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $388K | 0.02% |
9,728
+783
| +9% | +$31.2K |
|
967
International Bancshares
IBOC
$4.77B
| $387K | 0.01% |
9,749
+1,590
| +19% | +$64.1K |
|
968
Nu Skin
NUS
$247M
| $387K | 0.01% |
5,672
-174
| -3% | -$11.3K |
|
|
AXE
969
DELISTED
Anixter International Inc
AXE
| $386K | 0.01% |
5,078
-311
| -6% | -$22.9K |
|
970
LXP Industrial Trust
LXP
$3.53B
| $384K | 0.01% |
7,963
+223
| +3% | +$11.5K |
|
971
Pentair
PNR
$10.2B
| $384K | 0.01% |
8,087
+1,955
| +32% | +$91.4K |
|
|
ICPT
972
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $384K | 0.01% |
6,569
-813
| -11% | -$51.3K |
|
973
Affiliated Managers Group
AMG
$9.46B
| $383K | 0.01% |
1,866
+453
| +32% | +$87.8K |
|
974
B&G Foods
BGS
$285M
| $383K | 0.01% |
10,885
+1,463
| +16% | +$50.1K |
|
975
Mine Safety
MSA
$6.74B
| $383K | 0.01% |
4,945
+82
| +2% | +$6.54K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Profund Advisors held 1,510 positions worth $2.59B, up 8% from $2.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Profund Advisors deployed $86M of net new capital in Q4 2017, opening 76 new positions and adding to 812 existing holdings. Its largest new stake was New Relic, Inc.: 35,199 shares worth $2.03M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $6.94M trimmed.
- Profund Advisors's largest Q4 2017 buy was New Relic, Inc.: 35,199 shares worth $2.03M.
- Profund Advisors added most to Intel in Q4 2017, an estimated $9.73M increase.
- Profund Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $6.94M.
- Profund Advisors fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $4.07M.
- Profund Advisors's ten largest holdings make up 20% of its $2.59B portfolio in Q4 2017.
- Profund Advisors opened 76 new positions and closed 56 in Q4 2017.
- Profund Advisors's portfolio value rose 8% quarter-over-quarter to $2.59B.
Based on Profund Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.